
---
nice.evidencecategory: 
---

### Evidence Statement CG66HES09
Ramipril was found to be cost-effective compared to placebo, 2,971/LYG, Beard et al. (2001),263
and 2,486/LYG, Schadlich et al. (2004),264 (1,699/LYG, exchange rate 0.68, 13 March 2007).271

[@Bakris_2005]

[@Palmer_2004]

